May 01, 2009
Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic fibrosis
Creon delayed-release capsules are expected to be available in the 3rd quarter of 2009. The currently marketed formulation of Creon will continue to be available until the launch of the new FDA-approved product.
For more information call (800) 354-0026 or visit www.CREON-US.com.